Lowering inflammation without affecting LDL-c benefits aggressively treated CV patients - PACE-CME

Lowering inflammation without affecting LDLc benefits aggressively treated CV patients

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Novel insights in the management and prognosis of pulmonary hypertension
Novel insights in the management and prognosis of pulmonary hypertension
ESC 2017
Novel insights in the management and prognosis of pulmonary hypertension
- Prof Nazzareno Galiè
Take home messages of the ESC congress for better hypertension treatment
Take home messages of the ESC congress for better hypertension treatment
ESC 2017
Take home messages of the ESC congress for better hypertension treatment
- Dr. Clyde Jancy
Cardiovascular protection in type 2 diabetes
Cardiovascular protection in type 2 diabetes
ESC 2017
Cardiovascular protection in type 2 diabetes
- Prof. Lars Rydén
BP lowering with endovascular baroreflex amplification in resistant hypertension: the CALM-FIM study
BP lowering with endovascular baroreflex amplification in resistant hypertension: the CALM-FIM study
ESC 2017
BP lowering with endovascular baroreflex amplification in resistant hypertension: the CALM-FIM study
- Dr. Wilko Spiering